We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protective Effects of Sodium Nitrite Explored

By HospiMedica staff writers
Posted on 06 May 2005
An animal study has found that sodium nitrite may be useful for protecting and preserving tissue and organ function after heart attack, high-risk abdominal surgery, and organ transplantation.

Sodium nitrite is a naturally occurring chemical, commonly used as a meat preservative and to treat cyanide poisoning. More...
In a study published in the May 2005 issue of The Journal of Clinical Investigation, scientists found that low concentrations of sodium nitrite had a strong protective effect, preventing cell death in the hearts and livers of mice undergoing experimental heart attack and liver injury. An earlier study had shown that infusions of sodium nitrite into the human circulation leads to the production of nitric oxide (NO), a strong blood vessel dilating molecule that increases blood flow.

In the current study, the researchers compared the effects of both lower and higher concentrations of nitrite versus control treatments of saline or nitrate, which is related to nitrite but cannot convert to NO. They found that only low concentrations of nitrite provided protection against injury and believe the protective effect is related in some way to the conversion of nitrite to nitric oxide.

"The remarkable thing about nitrite is that it is only converted to nitric oxide in the organs and tissues with the lowest oxygen levels, allowing for targeted NO delivery--and thus improved blood flow--to tissues under stress,” explained Dr. Mark Gladwin, head of the vascular therapeutics section of the cardiovascular branch of the U.S. National Heart Lung Blood Institute (NHLBI, Bethesda, MD, USA), co-leader of the study. "More research is needed to look at the effectiveness of nitrite in various organs and disease states in humans.”

Dr. Gladwin is currently studying the use of sodium nitrite as a way to help adults with sickle cell disease, by reversing the effect of decreased blood flow due to patients' "sickled” blood cells. Other studies are planned or under way to evaluate the effect of sodium nitrite on heart attacks, kidney failure, solid organ transplantation, cerebral vasospasm, and high blood pressure in the lungs of babies.




Related Links:
NHLBI

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.